Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Nuwellis Inc (NUWE) vs Palantir Technologies Inc (PLTR) Price & Performance

Nuwellis IncTrade
Palantir Technologies IncTrade

Price performance (Past 24H)

Key statistics

Nuwellis Inc vs Palantir Technologies Inc — how do they compare? Nuwellis Inc trades at $0.8 (market cap $2.50M), while Palantir Technologies Inc trades at $169.62 (market cap $409.24B). The key difference: Palantir Technologies Inc is far larger — about 163696× Nuwellis Inc's market cap, and Palantir Technologies Inc is trading nearer its 52-week high, Nuwellis Inc nearer its low. Which is the better fit depends on your goals.

NUWEPLTR
Market Cap
$2.50M$409.24B
Sector
TechnologyTechnology
52-Week High
$164.50$207.18
52-Week Low
$0.73$107.27
Enterprise Value
-$1.21M$400.04B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Nuwellis Inc

NUWE trades at $0.7878, up 0.88% today, but remains in a bearish technical trend. The company shows strong gross margins of 69.69% and double-digit revenue growth, but faces significant profitability challenges with negative net income margins and ROE. Recent developments include a reverse stock split, new CEO appointment, and strategic partnerships expanding pediatric care footprint.

While NUWE demonstrates operational progress with revenue growth and margin improvement, persistent losses and negative cash flow present substantial risk. The mixed analyst sentiment and bearish technical indicators suggest cautious approach. Investment appeal hinges on successful execution of financial efficiency strategy and path to profitability.

Palantir Technologies Inc

Palantir (PLTR) trades at $170.30, down 2.31% on the day, with technical indicators showing neutral signals amid strong fundamental performance. The company reported exceptional Q2 2026 results with EPS of $0.41 beating expectations by 19%, while revenue growth accelerated to 93% year-over-year. Recent news highlights the strategic Nebius partnership for sovereign AI infrastructure, positioning Palantir to address growing enterprise demand for private AI deployment solutions.

While valuation metrics remain elevated with P/E of 145.6 and P/S of 71.1, the company's 49% net margin and 38.4% ROE demonstrate strong profitability. The consensus price target of $211.38 suggests 24% upside potential, though competitive pressures and high expectations create execution risks. Investors face the tension between premium valuation and exceptional growth trajectory.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Nuwellis Inc

Nuwellis, Inc. is a medical device company focused on developing and commercializing fluid management solutions. The company's primary product is an ultrafiltration system used in hospitals to remove excess fluid from patients with fluid overload, often associated with conditions such as heart and kidney failure. Nuwellis aims to improve patient outcomes and reduce healthcare costs through its specialized, innovative therapies.

Read more on NUWE

About Palantir Technologies Inc

Palantir Technologies provides organizations with solutions to manage large disparate data sets in an attempt to gain insight and drive operational outcomes. Founded in 2003, Palantir released its Gotham software platform in 2008, which focuses on the government intelligence and defense sectors. Palantir expanded into various commercial markets with its Foundry software platform in 2016 with the intent of becoming the data operating system for companies and industries. The Denver company had 125 customers as of its initial public offering and roughly splits its revenue between commercial and government customers.

Read more on PLTR